Stem cells and immunotherapy join forces against childhood brain tumors
NCT ID NCT07031765
First seen Sep 30, 2025 · Last updated May 18, 2026 · Updated 34 times
Summary
This early-phase trial tests a new approach for children whose high-grade glioma has returned after standard treatments. It combines specially grown stem cells with an immunotherapy drug (nivolumab) to see if the treatment is safe and possible to deliver. The study involves 12 children who are already scheduled for surgery to remove their tumor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HIGH-GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health Shands Children's Hospital/Shands Hospital
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.